Xeris Biopharma Holdings Inc Revenue per Employee (XERS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)
 

Xeris Biopharma Holdings Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 44.16% in the third quarter 2026, year on year to cumulative value of $368 million, Xeris Biopharma Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 5,665,523. The productivity of Xeris Biopharma Holdings Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 7 other companies have achieved higher revenue per employee. While Xeris Biopharma Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 141 to 191. Xeris Biopharma Holdings Inc has 65 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 44.16 % 28.74 % 38.27 % 42.78 % 37.06 %
Sales per Employee (TTM) $ 5,665,523 5,160,215 4,843,892 4,489,923 4,094,415
XERS's Total Ranking # 191 # 141 # 197 # 200 #
Seq. Revenue Change 16.42 % 10.79 % -3.12 % 15.36 % 3.97 %

XERS Company Profile >> Back to XERS Efficiency Comparisons >> Compare XERS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 8
Overall Market # 191

Revenue per Employee Statistics
High Average Low
$ 5,160,215 $ 1,942,548 $ 1,462
(Jun 30 2026)   (Sep 30 2019)



Financial Statements
Xeris Biopharma Holdings Inc 's Revenue MRQ $ 107 Millions Visit XERS's Income Statement
Xeris Biopharma Holdings Inc 's Revenues TTM $ 368 Millions Visit XERS's aggregate revenue growth
What are XERS's Sales? Visit XERS's Sales by Segment




Other Ratios
Xeris Biopharma Holdings Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
XERS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for XERS's Competitors
Revenue per Employee for XERS's Suppliers
Revenue per Employee for XERS's Customers

You may also want to know
XERS's Sales Growth Rates XERS's Pe Price to earnings ratio XERS's Receivables Turnover Ratio XERS's Stock Quote
XERS's Net Income Growth Rates XERS's Ps Price to Sales ratio XERS's Sales per Employee XERS's Asset Turnover Ratio
XERS's Net Margin XERS's Pb Price to Book ratio XERS's Financial Strength Ratios XERS's Dividend Payout Ratio
Date modified: 2026-11-07T13:26:03+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ligand Pharmaceuticals Incorporated  5,400,574.47 $ 253.827  Million 47 
Halozyme Therapeutics Inc   4,261,106.38 $ 1,802.448  Million 423 
Ironwood Pharmaceuticals inc   4,002,960.00 $ 400.296  Million 100 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Amgen Inc   2,992,538.46 $ 38,903.000  Million 13,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.